Want to see JP:5187 full AI Analyst Report?
5187 Stock Chart & Stats
¥1037.00
-¥1.00(-0.11%)
At close: 4:00 PM EST
¥1037.00
-¥1.00(-0.11%)
Day’s Range― - ―
52-Week Range¥975.00 - ¥1,244.00
Previous CloseN/A
Volume5.50K
Average Volume (3M)5.89K
Market Cap
¥10.30B
Enterprise Value¥5.00K
Total Cash (Recent Filing)¥5.64B
Total Debt (Recent Filing)¥749.70M
Price to Earnings (P/E)16.9
Beta0.28
Next Earnings
Nov 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.21%
Share Statistics
EPS (TTM)67.54
Shares Outstanding9,664,327
10 Day Avg. Volume3,600
30 Day Avg. Volume5,893
Financial Highlights & Ratios
PEG Ratio-1.05
Price to Book (P/B)0.53
Price to Sales (P/S)0.64
P/FCF Ratio88.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring Consumables DemandThe single-use nature of its infusion, transfusion, drainage and catheter-care products creates recurring replenishment demand. This supports revenue visibility because hospitals and clinics must continue purchasing supplies as procedures and patient care activities occur.
Conservative Balance SheetLow leverage and expanding equity provide financial flexibility for manufacturing investment, product development and working-capital needs. The limited debt burden also reduces solvency risk if healthcare purchasing conditions or operating profitability weaken.
Steady Revenue GrowthConsistent top-line expansion indicates continued demand for the company’s medical consumables and suggests its product portfolio and distribution channels are retaining market relevance. Sustained growth provides a foundation for operating improvement if cost control strengthens.
Bears Say
Inconsistent Cash GenerationUneven cash conversion can constrain the funds available for product development, capital spending and shareholder returns. The 2025 decline also raises execution risk around working capital or investment spending, even though the balance sheet remains conservative.
Volatile ProfitabilityProfit volatility indicates that stable sales have not consistently translated into earnings growth. Uneven cost control, operating expenses or non-recurring effects could limit margin sustainability and reduce the company’s ability to compound earnings over time.
Earnings Growth PressureNegative EPS growth alongside only modest recent revenue expansion suggests weaker earnings conversion and limited operating leverage. Unless profitability improves, slower growth in the core business may continue to weigh on earnings quality over the next several quarters.
Create Medic Co., Ltd. News
5187 FAQ
What was Create Medic Co., Ltd.’s price range in the past 12 months?
Create Medic Co., Ltd. lowest stock price was ¥975.00 and its highest was ¥1244.00 in the past 12 months.
What is Create Medic Co., Ltd.’s market cap?
Create Medic Co., Ltd.’s market cap is ¥10.30B.
When is Create Medic Co., Ltd.’s upcoming earnings report date?
Create Medic Co., Ltd.’s upcoming earnings report date is Nov 04, 2026 which is in 49 days.
How were Create Medic Co., Ltd.’s earnings last quarter?
Create Medic Co., Ltd. released its earnings results on Aug 05, 2026. The company reported ¥13.23 earnings per share for the quarter.
Is Create Medic Co., Ltd. overvalued?
According to Wall Street analysts Create Medic Co., Ltd.’s price is currently Overvalued.
Does Create Medic Co., Ltd. pay dividends?
Create Medic Co., Ltd. pays a Semiannually dividend of ¥27 which represents an annual dividend yield of 4.21%. See more information on Create Medic Co., Ltd. dividends here
What is Create Medic Co., Ltd.’s EPS estimate?
Create Medic Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Create Medic Co., Ltd. have?
Create Medic Co., Ltd. has 9,664,327 shares outstanding.
What happened to Create Medic Co., Ltd.’s price movement after its last earnings report?
Create Medic Co., Ltd. reported an EPS of ¥13.23 in its last earnings report. Following the earnings report the stock price went up 0.529%.
Which hedge fund is a major shareholder of Create Medic Co., Ltd.?
Currently, no hedge funds are holding shares in JP:5187
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Create Medic Co., Ltd.
Create Medic Co., Ltd. engages in the research, manufacturing, and sale of medical appliances in Japan, China, Vietnam, and internationally. The company offers urology products, including all silicone foley, antibacterial foley, hematuria, tieman, suprapubic, and nephrostomy balloon catheters, as well as self-catheterization set, all silicone self-catheter for replacement, pure-cath, nephrostomy kit, cystostomy set, and all silicone malecot catheter; and gastroenterology products, such as all silicone ileus, stomach, and sengstaken blakemore tubes, as well as transanal ileus decompression tube set. It also provides PEG products comprising PEG kit pull-method, with loop fixture, and bumper type, as well as CLINY introducer PEG kit, loop fixture II, all silicone gastrostomy balloon catheter for replacement, balloon button set, facil button for replacement, gastrostomy replacement catheter set, all silicone PEG J catheter, and transgastric jejunal balloon tube and guidewire set; surgery products, which include PTC drainage tube, PTCD kit, cholangio-entero tube, and internal external drainage catheter for PTCD; all silicone endotracheal and tracheostomy tubes and micro catheter; and OEM products. The company was formerly known as NASK Co., Ltd. and changed its name to Create Medic Co., Ltd. in July 1977. Create Medic Co., Ltd. was incorporated in 1974 and is headquartered in Yokohama, Japan.
Technical Analysis
PHC Holdings Corp.
―
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―